Unlimited medicalization? Risk and the pathologization of normality

Health, Risk and Vulnerability

Volumn , Issue , 2007, Pages 16-29

  Skolbekken, John Arne ^a  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 43349093432     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.4324/9780203933497     Document Type: Chapter

References (42)

1. Armstrong, D. (1983) The Political Anatomy of the Body: Medical Knowledge in Britain in the Twentieth Century. Cambridge: Cambridge University Press.
2. Armstrong, D. (1995) 'The rise of surveillance medicine', Sociology of Health and Illness 17: 393-404.
3. Borch-Johnsen, K., Colagiuri, S., Balkau, B., Glumer, C., Carstensen, B., Ramachandran, A. et al. (2004) 'Creating a pandemic of prediabetes: The proposed new diagnostic criteria for impaired fasting glycaemia'. Diabetologica 47:1396-402.
4. British Medical Association (1987) Living with Risk. Chichester: John Wiley and Sons.
5. Chobanian, A.V., Bakris, G.L., Black, H.R., Cushman, W.C., Green, L.A., Izzo, J.L. et al. (2003) 'The seventh report on the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: The JNC 7 report', JAMA289:2560-72.
6. Chockalingam, A., Ganesan, N., Venkatesan, S., Gnanavelu, G., Subramaniam, T., Jaganathan, V. et al. (2005) 'Patterns and predictors of prehypertension among "healthy" urban adults in India', Angiology 56: 557-63.
7. Conrad, P. (1992) 'Medicalization and social control', Annual Review of Sociology 18:209-32.
8. Conrad, P. (2005) 'The shifting engines of medicalization', Journal of Health and Social Behaviour 46: 3-14.
9. Davison, C., Davey Smith, G. and Frankel, S. (1991) 'Lay epidemiology and the prevention paradox: The implication of coronary candidacy for health education', Sociology of Health and Illness 13: 1-19.
10. Dean, M. (1999) Governmentality: Power and Rule in Modern Society. London: Sage Publications.
11. DeBacker, G., Ambrosioni, E., Borch-Johnsen, K., Brotons, C., Cifkova, R., Dallongeville, J. et al. (2003) 'European guidelines on cardiovascular disease prevention in clinical practice', European Heart Journal 24: 1601-10.
12. Førde, O.H. (1998) 'Is imposing risk awareness cultural imperialism?', Social Science and Medicine 47: 1155-9.
13. Forsmo, S., Langhammer, A. and Forsen, L. (2005) 'Forearm bone mineral density in an unselected population of 2,779 men and women-The HUNT study, Norway', Osteoporosis International 16: 562-7.
14. Getz, L., Kirkengen, A.L., Hetlevik, I., Romundstad, S. and Sigurdsson, J.A. (2004) 'Ethical dilemmas arising from implementation of the European guidelines on cardiovascular disease prevention in clinical practice', Scandinavian Journal of Primary Health Care 22: 202-8.
15. Gifford, S.M. (1986) 'The meaning of lumps: A case study of the ambiguities of risk', in C.R. Janes, R. Stall and S.M. Gifford (eds) Anthropology and Epidemiology:Interdisciplinary Approaches to the Study of Health and Disease. New York: D. Reidel Publishing Co.
16. Hetlevik, I. (2000) 'Tilbake til de syke-forebygging på legekontoret i krise', in E. Swensen (ed.) Diagnose Risiko. Oslo: Universitetsforlaget.
17. Hollnagel, H. (1999) 'Explaining risk factors to patients during a general practice consultation: Conveying group-based epidemiological knowledge to individual patients', Scandinavian Journal of Primary Health Care 17(1): 3-5.
18. Holmen, J., Midthjell, K., Krüger, Ø., Langhammer, A., Holmen, T.L., Bratberg, G.H. et al. (2003) 'The Nord-Trøndelag Health Study 1995-97 (HUNT 2): Objectives, contents, methods and participation', Norsk Epidemiologi 13: 19-32.
19. Law, M.R. and Wald, N.J. (2002) 'Risk factor thresholds: Their existence under scrutiny', BMJ324:1570-6.
20. Lupton, D. (1997) 'Foucault and the medicalization critique', in A. Petersen and R. Bunton (eds) Foucault, Health and Medicine. London: Routledge.
21. Malterud, K. (2002) 'Når livsstil ikke nytter-medikamentell risikointervension for dårlige mennesker', in K.T. Elvbakken and P. Solvang (eds) Helsebilder. Bergen:Fagbokforlaget.
22. Moynihan, R. and Cassels, A. (2005) Selling Sickness: How Drug Companies Are Turning Us All into Patients. Crows Nest: Allen and Unwin.
23. Moynihan, R., Bero, L., Ross-Degnan, D., Henry, D., Lee, K., Watkins, J. et al. (2000) 'Coverage by the news media of the benefits and risks of medication', New England Journal of Medicine 342: 1645-50.
24. Ogden, J. (1995) 'Psychosocial theory and the creation of the risky self ', Social Science and Medicine 40: 409-15.
25. Olin Lauritzen, S. and Sachs, L. (2001) 'Normality, risk and the future: Implicit communication of threat in health surveillance', Sociology of Health and Illness 23:497-516.
26. Petersen, A. and Lupton, D. (1996) The New Public Health: Health and Self in the Age of Risk. London: Sage Publications.
27. Robertson, A. (2001) 'Biotechnology, political rationality and discourses of health risk', Health 5: 293-309.
28. Rockhill, B. (2001) 'The privatization of risk', American Journal of Public Health 91:365-8.
29. Rodgers, A. (2003) 'A cure for cardiovascular disease?', BMJ326:1407-8.
30. Rose, N. (2001) 'The politics of life itself ', Theory, Culture & Society 18: 1-30.
31. Scott, S., Prior, L., Wood, F. and Gray, J. (2005) 'Repositioning the patient: The implications of being "at risk"', Social Science and Medicine 60: 1869-79.
32. Skolbekken, J.-A. (1995) 'The risk epidemic in medical journals', Social Science and Medicine 40: 291-305.
33. Skolbekken, J.-A. (1998) 'Communicating the risk reduction achieved by cholesterol reducing drugs', BMJ356:1956-8.
34. kolbekken, J.-A. (2000) 'Risiko for sykdom-vår tids epidemi?', in E. Swensen (ed.) Diagnose risiko. Oslo: Universitetsforlaget.
35. Skolbekken, J.-A. (2001) 'Risikoreduksjon på blå resept', in D. Thelle (ed.) På den usikre siden: Risiko som forestilling, atferd og rettesnor. Oslo: Cappelen Akademisk Forlag.
36. Smith, R. (2003a) 'The most important BMJ for 50 years?', BMJ326 (7404).
37. Smith, R. (2003b) 'Communicating risk: The main work of doctors', BMJ327 (7417).
38. Trouiller, P., Torreele, E., Olliaro, P., White, N. and Foster, S. (2001) 'Drugs for neglected diseases: A failure of the market and a public health failure?', Tropical Medicine and International Health 6: 945-51.
39. Wald, N.J. and Law, M.R. (2003) 'A strategy to reduce cardiovascular disease by more than 80%', BMJ326:1419-25.
40. Wang, Y.F. and Wang, O.J. (2004) 'The prevalence of prehypertension and hypertension among US adults according to the new Joint National Committee Guidelines', Archives of Internal Medicine 164: 2126-34.
41. WHO Study Group (1994) Assessment of Fracture Risk and its Application to Screening for Postmenopausal Osteoporosis. Geneva: WHO technical report series.
42. Williams, S.J. and Calnan, M. (1996) 'The "limits" of medicalization? Modern medicine and the lay populace in "late" modernity', Social Science and Medicine 42: 1609-20.